Acadian Asset Management
COCP icon

Acadian Asset Management’s Cocrystal Pharma COCP Stock Holding History

Acadian Asset Management’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-15,619
Closed -$133K – 2241
2020
Q1 		$133K Buy
15,619
+14,545
+1,354% +$137K ﹤0.01% 1291
2019
Q4 		$6K Hold
1,074
– – ﹤0.01% 1771
2019
Q3 		$26K Hold
1,074
– – ﹤0.01% 1691
2019
Q2 		$30K Hold
1,074
– – ﹤0.01% 1552
2019
Q1 		$35K Hold
1,074
– – ﹤0.01% 1741
2018
Q4 		$46K Buy
1,074
+912
+563% +$30.1K ﹤0.01% 1438
2018
Q3 		$5K Buy
+162
New +$7.25K ﹤0.01% 1620

Other funds holding COCP

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EU
Emory University Atlanta, Georgia $267M AUM 48.26% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Acadian Asset Management's COCP Position: Q2 2020 in Review

Acadian Asset Management sold out of Cocrystal Pharma (COCP) in Q2 2020, closing a stake of 15,619 shares — an estimated $133K sold.

Acadian Asset Management first reported a position in COCP in Q3 2018 and held it in 7 quarters. The position peaked at $133K in Q1 2020. 21 funds tracked by Wall St. Rank hold COCP as of Q2 2020.

  • Acadian Asset Management reported no remaining Cocrystal Pharma position as of Q2 2020 after selling out during the quarter.
  • Acadian Asset Management sold 15,619 Cocrystal Pharma shares in Q2 2020, an estimated $133K.
  • Acadian Asset Management first reported a position in Cocrystal Pharma in Q3 2018 and held it in 7 quarters.
  • Acadian Asset Management's Cocrystal Pharma position peaked at $133K in Q1 2020.
  • 21 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q2 2020.

Based on Acadian Asset Management's 13F filing for Q2 2020, filed 12 Aug 2020.